Biomerica (BMRA) Deferred Taxes (2010 - 2016)

Biomerica (BMRA) reported Deferred Taxes of -$957000.0 for Q2 2016, down 865.6% sequentially from $125000.0 in Q1 2016.

Biomerica (BMRA) Deferred Taxes (2010 - 2016) Analysis & Trends

Biomerica (BMRA) has 3 years of Deferred Taxes data on file, last reported at -$957000.0 in Q2 2016.

For the quarter ending Q2 2016, Deferred Taxes changed N/A year-over-year to -$957000.0; the trailing twelve-month figure through May 2016 stood at -$830446.0 (changed N/A YoY), and the FY2019 full-year result was -$10000.0, up 67.74% from the prior year.
Deferred Taxes slipped to -$957000.0 in Q2 2016, from $125000.0 in the prior quarter.
In the past five years, Deferred Taxes ranged from a high of $125000.0 in Q1 2016 to a low of -$957000.0 in Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	-33.00 Mn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	-8.00 Mn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-351.00 Mn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-9.40 Mn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	7.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	51.51 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	-
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Biomerica	4.85 Mn	3.51 Mn	-44,000.00	-

Download Data